bluebird bio (BLUE)
(Delayed Data from NSDQ)
$0.53 USD
-0.04 (-7.00%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $0.53 0.00 (0.21%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: BMO |
6/2024 | $-0.47 | -27.14% |
Earnings Summary
For their last quarter, bluebird bio (BLUE) reported earnings of -$0.66 per share, beating the Zacks Consensus Estimate of $-0.69 per share. This reflects a positive earnings surprise of 4.35%. Look out for BLUE's next earnings release on August 14, 2024. For the next earning release, we expect the company to report earnings of -$0.47 per share, reflecting a year-over-year increase of 29.85%.
Earnings History
Price & Consensus
Zacks News for BLUE
Y-mAbs Therapeutics, Inc. (YMAB) Reports Q2 Loss, Misses Revenue Estimates
BLUE: What are Zacks experts saying now?
Zacks Private Portfolio Services